Tomorrow’s Breakthroughs Today features world-class scientists discussing the path toward new, cutting-edge treatments for Alzheimer’s disease. Now in its sixth season, this lecture series, founded in partnership with Heidi and Tom McWilliams, invites three top investigators to share the latest breaking updates on their research with moderator Laura Nisenbaum, PhD, Interim Chief Science Officer of the Alzheimer’s Drug Discovery Foundation (ADDF). Founded in 1998 by Leonard A. Lauder and Ronald S. Lauder, the ADDF is dedicated to rapidly accelerating the development of novel therapeutics and biomarkers to prevent, treat, and cure Alzheimer’s disease and related dementias.

Rewiring Alzheimer's: The Promise of Neuromodulation
Stiller Family Foundation Auditorium at the Norton Museum of Art 
3:00pm – November 30, 3026

Explore the promise of neuromodulation with Christian Howell, Chief Executive Officer of Cognito Therapeutics, and learn how innovative medical devices may help reshape the future of Alzheimer’s treatment.

Blood Tests and Beyond: Redefining Alzheimer's Care Through Biomarkers
Fitz Eugene Dixon Education Building at The Society of the Four Arts
5:30pm - January 26, 2027
*Tickets for the January 26, 2027, symposium is available through the Society of the Four Arts website.

Hear from Dr. Anthony "Nino" Sireci; Senior Vice President of Clinical Biomarkers, Laboratories, and Diagnostics at Eli Lilly and Company; on how biomarkers, including blood-based tests, are transforming Alzheimer’s research, diagnosis, and care. 

Preventing Alzheimer's: The Importance of Early Detection and Personalized Risk Reduction
Stiller Family Foundation Auditorium at the Norton Museum of Art 
3:00pm - March 31, 2027

Discover the growing science of Alzheimer’s prevention with Dr. Kellyann Niotis, preventive neurologist, who will discuss early detection, brain health, and personalized risk reduction.